Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: Comparison with clonidine

Journal of Autonomic Pharmacology

Volumn 16, Issue 1, 1996, Pages 13-20

  Boucher, M ^a,b   Dubar, M ^c   Chapuy, E ^a   Chassaing, C ^a  

^a INSERM   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; PHENOXYBENZAMINE; PINDOLOL; RILMENIDINE; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CHRONOTROPISM; CONTROLLED STUDY; DOG; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN;

EID: 0030006880     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00351.x     Document Type: Article

References (40)

1. BEAU, B., MAHIEUX, F., PARAIRE, M., LAURIN, S., BRISGAND, B. & VITOU, P. (1988). Efficacy and safety of rilmenidine for arterial hypertension. Am. J. Cardiol., 61, 95D-102D.
2. BOUCHER, M., CHASSAING, C., CHAPUY, E. & DUCHENE-MARULLAZ, P. (1994a). Chronotropic cardiac effects of falipamil in conscious dogs: interactions with the autonomic nervous system and various ionic conductances. J. Cardiovasc. Pharmacol., 23, 569-575.
3. BOUCHER, M., CHASSAING, C., CHAPUY, E. & LORENTE, P. (1994b). Chronotropic cardiac effects of NPY in conscious dogs: interactions with the autonomic nervous system and putative NPY receptors. Regul. Pept., 54, 409-415.
4. BOUCHER, M., DUBAR, M., CHASSAING, C., VIVET, P. & DUCHENE-MARULLAZ, P. (1994c). Cardiac electrophysiological effects of rilmenidine, a novel antihypertensive agent, in the conscious dog: comparison with clonidine. Life Sci., 54, PL381-387.
5. BOUCHER, M., DUBRAY, C. & DUCHENE-MARULLAZ, P. (1982a). Mécanismes de l'action bradycardisante de la clonidine cher le chien non narcose en bloc auriculoventriculaire chronique. J. Pharmacol., 13, 459.
6. BOUCHER, M., DUBRAY, C. & DUCHENE-MARULLAZ, P. (1982b). Long-term observation of atrial and ventricular rates in the unanaesthetized dog with complete atrioventricular block. Pflügers Arch., 395, 341-343.
7. BOUCHER, M. & DUCHENE-MARULLAZ, P. (1980). Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency. Br. J. Pharmacol., 70, 335-340.
8. BOUCHER, M. & DUCHENE-MARULLAZ, P. (1985). Methods for producing experimental complete atrio-ventricular block in dogs. J. Pharmacol. Methods, 13, 95-107.
9. 2-adrenoceptors mediating catecholamine-induced negative chronotropic ventricular responses in the conscious dog. Gen. Pharmacol., 21, 791-798.
10. BOUCHER, M., DUCHENE-MARULLAZ, P. & LAVARENNE, J. (1979). Catecholamines and cardiac rhythms in the unanesthetized dog with chronic AV block. Am. J. Physiol., 237, H10-H17.
11. BRICCA, G., DONTENWILL, M., MOLINES, A., FELDMAN, J., TIBIRICA, E., BELCOURT, A. & BOUSQUET, P. (1989). Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol., 163, 373-377.
12. 3H]-clonidine. Eur. J. Pharmacol., 266, 25-33.
13. CHASSAING, C., GODENECHE, D., BOUCHER, M. & DUCHENE-MARULLAZ, P. (1979). A comparison of changes in atropine-induced tachycardia and atropine concentration in conscious dogs. Eur. J. Pharmacol., 58, 433-441.
14. DOLLERY, C.T., DAVIES, D.S., DUCHIER, J., PANNIER, B. & SAFAR, M.E. (1988). Dose and concentration-effect relations for rilmenidine. Am. J. Cardiol., 61, 60D-66D.
15. DUCHENE-MARULLAZ, P., COMBRE, A., LAVARENNE, J., LAPALUS, P. & SCHAFF, G. (1975). Comparaison des effets du propranolol, de l'alprénolol, du pindolol et du practolol sur les rythmes cardiaques de chiens non narcosés en dissociation auriculoventriculaire chronique. J. Pharmacol., 6, 441-452.
16. DUCHENE-MARULLAZ, P., LAVARENNE, J., LAPALUS, P., BOUCHER, M. & MONGHEAL, Y. (1974). Effect of clonidine on heart rate in dogs with acute or chronic heart block. Eur. J. Pharmacol., 28, 76-80.
17. EHRHARDT, J.D. (1985). Gas chromatography negative ion mass spectrometric assay of 2-dicyclopropylmethylamino-2-oxazoline (S3341), a new antihypertensive drug. Biomed. Mass Spectrom., 12, 593-595.
18. FELDMAN, J., TIBIRICA, E., BRICCA, G., DONTENWILL, M., BELCOURT, A. & BOUSQUET, P. (1990). Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol., 100, 600-604.
19. GOMEZ, R.E., ERNSBERGER, P., FEINLAND, G. & REIS, D.J. (1991). Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol., 195, 181-191.
20. 3H]-idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur. J. Pharmacol., 146, 345-348.
21. HOEFKE, W. & KOBINGER, W. (1966). Pharmakologische Wirkungen des 2-(2,6-dichlorophenylamino)-2-imidazolin hydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittelforschung, 16, 1038-1050.
22. HORDOF, A.J., ROSE, E., DANILO, P. JR. & ROSEN, M.R. (1982). Alpha- and beta-adrenergic effects of epinephrine on ventricular pacemakers in dogs. Am. J. Physiol., 242, H677-H682.
23. JOHANSSON, P. (1984). Alpha-adrenoceptors: recent development and some comparative aspects. Comp. Biochem. Physiol., 78C, 253-261.
24. KOENIG-BERARD, E., TIERNEY, C., BEAU, B., DELBARRE, B., LHOSTE, F. &: LABRID, C. (1988). Cardiovascular and central nervous system effects of rilmenidine (S3341) in rats. Am. J. Cardiol., 61, 22D-31D.
25. 2-categories: relevance to antihypertensive therapy. In: New Trends in Arterial Hypertension, pp 73-85. Eds M. WORCEL, J.P. BONVALET, S.Z. LANGER, J. MENARD & J. SASSARD. Elsevier/North-Holland Biomedical Press, Amsterdam.
26. 2-adrenoceptor agonist. J. Pharmacol., 16, 259-278.
27. LAURENT, S. & SAFAR, M. (1992). Rilmenidine: a novel approach to first-line treatment of hypertension. Am. J. Hyperten., 5, 99S-105S.
28. LI, J.H., BOUCHER, M. & DUCHENE-MARULLAZ, P. (1986). Chronotropic cardiac effects of histamine in the conscious dog with chronic atrioventricular block: interactions with the autonomic nervous system. Agents Actions, 19, 150-157.
29. 2-adrenergic receptor binding sites. Eur. J. Pharmacol., 94, 171-174.
30. REYNOLDS, R.D. & DI SALVO, J. (1978). Effects of dl-propranolol on atrial and ventricular rates in unanesthetized atrioventricular blocked dogs. J. Pharmacol. Exp. Ther., 205, 374-581.
31. RIGEL, D.F., LIPSON, D. & KATONA, P.G. (1984). Excess tachycardia: heart rate after antimuscarinic agents in conscious dogs. Am. J. Physiol., 246, H168-H173.
32. ROBINSON, J.L., FARR, W.C. & GRUPP, G. (1973). Atrial rate response to ventricular pacing in the unanesthetized A-V blocked dog. Am. J. Physiol., 224, 40-45.
33. RUFFOLO, R.R. JR. (1985). Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system. Pharmacol. Biochem. Behav., 22, 827-833.
34. SANNAJUST, F. & HEAD, G.A. (1994). Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J. Cardiovasc. Pharmacol., 23, 42-50.
35. SCHMITT, H. & FENARD, S. (1970). Influence de l'atropine, des ganglioplégiques et de la bivagotomie sur les effets hémodynamiques de la clonidine. J. Pharmacol., 1, 359-368.
36. SPIERS, J.P., HARRON, D.W.G. & WILSON, R. (1990). Acute and chronic effects of rilmenidine on baroreflex function in conscious dogs. Eur. J. Pharmacol., 181, 235-240.
37. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 593-600.
38. TONET, J., GUILLET, C., JONDEAU, G., POULAIN, F., VIVET, P., FRANK, R. & GROSGOGEAT, Y. (1991). Electrophysiological effects of intravenous rilmenidine in man. Eur. J. Clin. Pharmacol., 41, 537-540.
39. UNG, H.L., GIRAULT, J., LEFEBVRE, M.A., MIGNOT, A. & FOURTILLAN, J.B. (1987). Quantitative analysis of S3341 in human plasma and urine by combined gas chromatography-negative ion chemical ionisation mass spectrometry: 15 month inter-day precision and accuracy validation. Biomed. Mass Spectrom., 14, 289-293.
40. 2-adrenoceptor agonist rilmenidine. Am. J. Cardiol., 61, 6D-14D.